J. Collette

发表

Vitamin D inadequacy in Belgian postmenopausal osteoporotic women

J. Reginster, O. Bruyère, A. Neuprez, 2007, BMC public health.

A cross-sectional evaluation of adiponectin plasma levels in patients with schizophrenia and schizoaffective disorder

J. Reginster, J. Peuskens, A. Scheen, 2008, Schizophrenia Research.

An unusual interference in parathormone assay caused by anti-goat IgG: a case report

E. Cavalier, J. Chapelle, P. Delanaye, 2009, Clinical chemistry and laboratory medicine.

The Effect of Sodium Monofluorophosphate plus Calcium on Vertebral Fracture Rate in Postmenopausal Women with Moderate Osteoporosis

J. Reginster, H. Minne, L. Rovati, 1998, Annals of Internal Medicine.

Vitamin D inadequacy in French osteoporotic and osteopenic women.

J. Reginster, O. Bruyère, C. de Cock, 2008, Joint, bone, spine : revue du rhumatisme.

Increase in cytokine production (IL-1 beta, IL-6, TNF-alpha but not IFN-gamma, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis.

J. Reginster, D. de Groote, N. Franchimont, 1997, Maturitas.

New radioimmunoassay for determination of bone specific iso-enzymes of serum alkaline phosphatases activity (Ostase°): validation and clinical perspective

J. Reginster, P. Franchimont, J. Collette, 1993 .

Bone Resorption in Post-menopausal Women with Normal and Low BMD Assessed with Biochemical Markers Specific for Telopeptide Derived Degradation Products of Collagen Type I

C. Christiansen, O. Bruyère, Y. Henrotin, 2001, Calcified Tissue International.

Role of biochemical markers of bone turnover as prognostic indicator of successful osteoporosis therapy.

J. Reginster, O. Bruyère, A. Neuprez, 2008, Bone.

Evaluation of different bone markers in hemodialyzed patients.

E. Cavalier, J. Chapelle, P. Delanaye, 2006, Clinica chimica acta; international journal of clinical chemistry.

Influence of specific anti-salmon calcitonin antibodies on biological effectiveness of nasal salmon calcitonin in Paget's disease of bone.

J. Reginster, P. Franchimont, C. Gennari, 1990, Scandinavian journal of rheumatology.

Effect of transforming growth factor-β1 on the insulin-like growth factor system in cultured porcine Leydig cells

M. Benahmed, P. Franchimont, M. Chauvin, 1994, Molecular and Cellular Endocrinology.

Simultaneous assays of cancer‐associated antigens in various neoplastic disorders

P. Franchimont, J. Collette, A. Reuter, 1976, Cancer.

Characterization of the IGF system and analysis of the possible molecular mechanisms leading to IGF-II overexpression in a mesothelioma.

J. Legros, L. Delacroix, P. Lefèbvre, 1997, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids.

J. Reginster, P. Sambrook, D. Reid, 2013, Rheumatology.

Administration of a supplement containing both calcium and vitamin D is more effective than calcium alone to reduce secondary hyperparathyroidism in postmenopausal women with low 25(OH)vitamin D circulating levels

J. Reginster, J. Collette, R. Deroisy, 2002, Aging clinical and experimental research.

Tumor IGF‐II content in a patient with a colon adenocarcinoma correlates with abnormal expression of the gene

P. Franchimont, C. Desaive, J. Collette, 1991, International journal of cancer.

Presence of alpha-lactalbumin, epidermal growth factor, epithelial membrane antigen, and gross cystic disease fluid protein (15,000 daltons) in breast cyst fluid.

P. Franchimont, J. Collette, J. Hendrick, 1986, Cancer research.

Tumor necrosis factor alpha stimulates insulin-like growth factor binding protein 3 expression in cultured porcine Sertoli cells.

M. Benahmed, B. Le Magueresse-Battistoni, J. Collette, 1996, Endocrinology.

Epithelial membrane antigen (EMA) distribution in various biological fluids.

P. Franchimont, S. Claes, J. Collette, 1988, European journal of cancer & clinical oncology.

Comparison of the short-term effects of three oral calcium-vitamin D formulations and placebo on calcium metabolism

J. Reginster, J. Collette, R. Deroisy, 1998 .

Effects of a hydrosoluble bacterial extract from Escherichia coli (OM-89) on cytokine production by peripheral blood mononuclear cells from healthy subjects and patients with rheumatoid arthritis.

P. Franchimont, N. Franchimont, J. Collette, 1991, Scandinavian journal of rheumatology.

Value of biomarkers in osteoarthritis: current status and perspectives

C. Cooper, C. Christiansen, O. Bruyère, 2013, Annals of the rheumatic diseases.

Republished: Value of biomarkers in osteoarthritis: current status and perspectives

C. Cooper, M. Karsdal, C. Christiansen, 2013, Postgraduate Medical Journal.

Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study

S Zaim, C Peterfy, J. Reginster, 2006, Annals of the rheumatic diseases.

Placental alkaline phosphatase in developing normal and abnormal gonads and in germ-cell tumours

Y. Gillerot, J. Hustin, P. Franchimont, 2005, Virchows Archiv A.

Immunohistochemical demonstration of placental alkaline phosphatase in various states of testicular development and in germ cell tumours.

J. Hustin, P. Franchimont, J. Collette, 1987, International journal of andrology.

Immunohistochemical detection of alphalactalbumin in breast lesions.

F. Spyratos, P. Franchimont, V. Le Doussal, 1984, European journal of cancer & clinical oncology.

[Biological rhythms and tumor markers in man. With special reference to the carcinoembryonic antigen (CEA) and alpha fetoprotein (AFP) in digestive system tumors].

F. Lévi, W. Hrushesky, C. Focan, 1987, Acta gastro-enterologica Belgica.

Cancer-associated alteration of circadian rhythms in carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in humans.

F. Lévi, W. Hrushesky, C. Focan, 1986, Anticancer research.

Circadian CEA variability: when to sample.

V. Castronovo, F. Lévi, C. Focan, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Partial purification of carcinoembryonic-reactive antigen from breast neoplasms using lectin and antibody affinity chromatography.

P. Franchimont, J. Collette, R. Santen, 1980, Cancer research.

Radioimmunoassay for human type II collagen.

Y. Henrotin, P. Franchimont, B. Nusgens, 1990, Journal of immunoassay.

Alpha-lactalbumin and GCDFP-15 as breast tumor markers (an opportunity to study breast tumors functionally).

J. Hustin, P. Franchimont, V. Le Doussal, 1987, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Presence of a-Lactalbumin, Epidermal Growth Factor, Epithelial Membrane Antigen, and Gross Cystic Disease Fluid Protein (15,000 Daltons) in Breast Cyst Fluid1

P. Franchimont, J. Collette, J. Hendrick, 2006 .

Epidermal Growth Factor and Prolactin in Human Breast Cyst Fluid a

P. Franchimont, A. Carlisi, J. Collette, 1990 .

Epidermal growth factor and prolactin in human breast cyst fluid. Possible correlations with GCDFP-15.

P. Franchimont, A. Carlisi, J. Collette, 1990, Annals of the New York Academy of Sciences.

Progression in MCF-7 breast cancer cell tumorigenicity: compared effect of FGF-3 and FGF-4

J. Foidart, A. Noël, A. Hajitou, 2000, Breast Cancer Research and Treatment.

Insulin‐like growth factor II in two human colon‐carcinoma cell lines: Gene structure and expression, and protein secretion

P. Franchimont, A. Carlisi, J. Collette, 1992, International journal of cancer.

Biochemical markers of bone and cartilage remodeling in prediction of longterm progression of knee osteoarthritis.

Olivier Ethgen, J. Reginster, O. Bruyère, 2003, The Journal of rheumatology.

Correction of vitamin D insufficiency with combined strontium ranelate and vitamin D3 in osteoporotic patients.

J. Reginster, R. Rizzoli, J. Kaufman, 2014, European journal of endocrinology.

Immunohistochemistry of a component protein of the breast cystic disease fluid with mol. wt 15,000.

F. Spyratos, P. Franchimont, V. Le Doussal, 1985, European journal of cancer & clinical oncology.

Dual photon absorptiometry of lumbar spine in West European (Belgian) postmenopausal females: normal range and fracture threshold

J. Reginster, P. Franchimont, J. Collette, 1990, Clinical Rheumatology.

Relationship between whole plasma calcitonin levels, calcitonin secretory capacity, and plasma levels of estrone in healthy women and postmenopausal osteoporotics.

J. Reginster, P. Franchimont, J. Collette, 1989, The Journal of clinical investigation.

Interest of biochemical markers of bone turnover for long-term prediction of new vertebral fracture in postmenopausal osteoporotic women.

J. Reginster, O. Bruyère, P. Delmas, 2003, Maturitas.

One-year increase of Coll 2-1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progression.

Y. Henrotin, L. Seidel, J. Reginster, 2005, Osteoarthritis and cartilage.

biochemical markers: a one year prospective study Osteoarthritis, magnetic resonance imaging, and

H. Genant, T. Montague, M. Kothari, 2009 .

Biological and clinical assessment of a new bisphosphonate, (chloro-4 phenyl) thiomethylene bisphosphonate, in the treatment of Paget's disease of bone.

J. Reginster, P. Franchimont, J. Collette, 1988, Bone.

Strontium ranelate (Fujisawa/Servier).

J. Reginster, Y. Henrotin, J. Collette, 2005, Current opinion in investigational drugs.

FGF-3 and FGF-4 elicit distinct oncogenic properties in mouse mammary myoepithelial cells

J. Foidart, M. Mareel, E. Bruyneel, 1998, Oncogene.

Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: Results from a 3-month prospective open-label study

J. Reginster, J. Peuskens, A. Scheen, 2011, European Neuropsychopharmacology.

Highest Prevalence of Vitamin D Inadequacy in Institutionalized Women Compared with Noninstitutionalized Women: A Case–Control Study

J. Reginster, O. Bruyère, J. Collette, 2009, Women's health.

Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis

S. Ortolani, M. Diaz-Curiel, J. Reginster, 2009, Osteoporosis International.

Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover

T. Spector, J. Reginster, O. Bruyère, 2009, Osteoporosis International.

PREVENTION OF POSTMENOPAUSAL BONE LOSS BY TILUDRONATE

J. Reginster, P. Franchimont, J. Collette, 1989, The Lancet.

[Preoperative and postoperative measurement of carcinoembryonic antigen (CEA): a prognostic factor in surgically treated rectocolic neoplasms?].

J. Reginster, P. Franchimont, C. Desaive, 1985, Revue Medicale de Liege.

Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate.

J. Reginster, O. Bruyère, L. Tankó, 2004, Clinical and experimental rheumatology.

Serum sclerostin levels in men with idiopathic osteoporosis.

B. Lapauw, S. Goemaere, H. Zmierczak, 2013, European journal of endocrinology.

Prevalence of vitamin D inadequacy in European postmenopausal women

J. Reginster, O. Bruyère, O. Malaise, 2007, Current medical research and opinion.

Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk.

J. Reginster, O. Bruyère, Y. Henrotin, 2004, Bone.

Stimulatory effect of oestradiol-17 beta and tamoxifen on gross cystic disease fluid protein 15,000 production and mRNA levels in T47D human breast cancer cells.

P. Franchimont, D. Haagensen, J. Collette, 1991, Journal of molecular endocrinology.

Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years

J. Reginster, O. Bruyère, R. Rizzoli, 2010, Osteoporosis International.

IGF-II in primary human colorectal tumors: peptide level, activated promoters, parental imprinting and gene rearrangement.

L. Delacroix, R. Winkler, J. Collette, 1999, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.